Plumbagin exhibits cytotoxicity in rodent models of carcinogenesis and carcinoma and shows has antifungal, antiviral, and antibacterial action. Plumbagin also suppresses CXCR4 expression, a key component of cancer metastasis studies.
Hsu, Y.L., et al., , Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J. Pharmacol. Exp. Ther. 318, 484-494, (2006) Sugie, S., et al., Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 127, 177-183, (1998) Inbaraj, J.J., and Chignell, C.F., Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. Chem. Res. Toxicol. 17, 55-62, (2004) Jaiswal, A.S., et al., Long-patch base excision repair of apurinic/apyrimidinic site DNA is decreased in mouse embryonic fibroblast cell lines treated with plumbagin: involvement of cyclin-dependent kinase inhibitor p21Waf-1/Cip-1. Oncogene 21, 5912-5922, (2002)
See how others have used Plumbagin (CAS 481-42-5). Click on the entry to view the PubMed entry .
PMID: # 31227705 2019. Nat Commun. 10: 2745.
PMID: # 28249720 Zhang, J. et al. 2017. Arch. Biochem. Biophys. 619: 16-26.
PMID: # 22669514 Patridge, EV. et al. 2012. Arch. Toxicol. 86: 1613-25.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.